NIH-funded research R37 grant

Aging, DNA Methylation, and Cardio Risk in Breast Cancer Survivors

Official title: Aging, DNA methylation, and incident cardiovascular disease in breast cancer survivors

Funded at H. Lee Moffitt Cancer Ctr & Res Inst · NIH-11378753 · Data updated 2026-11-12

A study to help breast cancer survivors understand how aging and DNA changes might raise the chance of heart disease.

More Breast Cancer research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionH. Lee Moffitt Cancer Ctr & Res Inst
NIH-funded
Lab location1 site (Tampa, United States)
Project startAugust 1, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$655,534
NIH project number5R37CA299472-02
Project IDNIH-11378753 on NIH RePORTER

Who could benefit from this research

Could help

Breast cancer survivors who have completed initial cancer treatment and are at risk for cardiovascular disease may be eligible.

Less likely to help

Patients without breast cancer history or those not at risk for cardiovascular disease may derive less direct benefit.

What this research studies

This project looks at how aging-related DNA methylation and biological aging markers relate to cardiovascular disease risk in breast cancer survivors. Researchers will examine DNA from blood samples and identify methylation patterns that could predict who is at higher heart-disease risk after cancer treatment. The study aims to fine-tune risk models for breast cancer patients so clinicians can tailor heart-monitoring and treatment decisions. If successful, these biomarkers could lead to earlier intervention and personalized care for survivors. The effort involves follow-up with patients and analysis of their clinical and biomarker data over time.

Why it matters

Potential benefit: Better, personalized heart-health risk prediction for breast cancer survivors could guide prevention and treatment decisions.

How similar studies have gone: Prior work suggests DNA methylation and aging markers relate to cardiovascular risk, but applying this to breast cancer survivors is an emerging area.

Where this research is happening

  • H. Lee Moffitt Cancer Ctr & Res Inst
    Tampa, United States
    Active

Researchers

  • Principal investigator: Kresovich, Jacob K — H. Lee Moffitt Cancer Ctr & Res Inst
  • Study coordinator: Kresovich, Jacob K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.